Confronta i metodi

	Brief Addiction Monitor (BAM)	Test di Identificazione del Disturbo da Uso di Cannabis	Drug Use Disorders Identification Test (DUDIT)	Opioid Risk Tool (ORT)
Campo	Medicina delle dipendenze	Medicina delle dipendenze	Medicina delle dipendenze	Medicina delle dipendenze
Famiglia	Process / pipeline	Process / pipeline	Process / pipeline	Process / pipeline
Anno di origine	2013	2010	2005	2005
Ideatore	Cacciola, Alterman, Drapkin, Valadez	Adamson, Kay-Lambkin, Baker, Lewin, Thornton, Kelly, Sellman	Berman, Bergman, Palmstierna, Schlyter	Webster, Webster
Tipo	Self-report	Self-report	Self-report	Self-report
Fonte seminale	Cacciola, J. S., Alterman, A. I., Drapkin, M. L., & Valadez, C. (2013). Development and initial validation of the Brief Addiction Monitor (BAM). Journal of Substance Abuse Treatment, 44(3), 256–263.	Adamson, S. J., Kay-Lambkin, F. J., Baker, A. L., Lewin, T. J., Thornton, L., Kelly, B. J., & Sellman, J. D. (2010). An improved brief screening instrument for cannabis use disorder. Drug and Alcohol Dependence, 110(1–2), 55–60.	Berman, A. H., Bergman, H., Palmstierna, T., & Schlyter, F. (2005). Evaluation of the Drug Use Disorder Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. European Addiction Research, 11(1), 22–31.	Webster, L. R., & Webster, R. M. (2005). Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Medicine, 6(6), 432–442.
Alias	BAM	CUDIT-R, CUDIT	DUDIT	ORT
Correlati	4	4	4	4
Sintesi	The BAM is a 17-item self-report instrument designed to provide rapid, multimodal assessment of substance use, craving, risk factors, protective factors, and psychosocial functioning in individuals receiving addiction treatment. Developed by Cacciola and colleagues in 2013, it serves as an efficient outcome monitoring tool for tracking treatment progress, identifying relapse warning signs, and guiding therapeutic adjustments. The BAM is useful in treatment settings where frequent assessment of multiple domains is needed to optimize care.	The CUDIT-R is a brief, 8-item self-report screening instrument developed to identify cannabis use disorder and hazardous cannabis use patterns. Introduced by Adamson and colleagues in 2010 as a revision of the original CUDIT, the CUDIT-R improves brevity and screening efficiency while maintaining strong psychometric properties. It is designed for use in primary care, addiction treatment, and public health settings to detect problematic cannabis use and inform treatment allocation decisions.	The DUDIT is a brief, gender-sensitive screening instrument designed to identify individuals with harmful or hazardous drug use patterns across a wide range of substances. Developed by Berman and colleagues in 2005, it serves as a primary care and public health screening tool to detect drug-related problems before they escalate to dependence or disorder. The DUDIT is freely available and has been validated in multiple languages and settings.	The ORT is a brief, 10-item self-report screening instrument designed to identify patients at elevated risk for opioid misuse, addiction, or aberrant drug-related behaviors prior to initiating opioid therapy. Developed by Webster and Webster in 2005, it stratifies patients into low, moderate, and high risk categories based on personal and family history of substance abuse, psychiatric comorbidity, and psychosocial factors. The ORT is widely used in pain management and primary care settings to guide shared decision-making and risk mitigation strategies when prescribing opioids.